GlassScriptPhysician profile
Mohammed Elamir
NPI 1811371420
$1,517.54
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $688 · 2020: $382 · 2021: $245 · 2022: $119 · 2024: $82.34.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $82.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $82.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $215.97 | 2021-2022 | |
| Edwards Lifesciences Corporation | $148.82 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $133.99 | 2019-2020 | |
| Lilly USA, LLC | $120.76 | 2019-2020 | |
| Glaxosmithkline, LLC. | $109.31 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $105.63 | 2019-2020 | |
| Novo Nordisk INC | $88.12 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $71.80 | 2019-2020 | |
| Mannkind Corporation | $65.66 | 2019-2020 | |
| Gilead Sciences, INC. | $64.88 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $51.69 | 2019-2020 | |
| Allergan, INC. | $51.34 | 2019 | |
| Electromed, INC. | $51.26 | 2024 | Smartvest |
| Takeda Pharmaceuticals U.S.A., INC. | $50.06 | 2019 | |
| Inspire Medical Systems, INC. | $31.08 | 2024 | Inspire |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $30.00 | 2020 | |
| Hikma Pharmaceuticals USA | $27.49 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $26.06 | 2019-2020 | |
| Amgen INC. | $19.29 | 2020 | |
| Boston Scientific Corporation | $17.50 | 2019 | |
| Avion Pharmaceuticals | $12.86 | 2020 | |
| Celgene Corporation | $12.64 | 2019 | |
| Genentech USA, INC. | $11.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammed Elamir listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.